Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eukaryotic Initiation Factor-2 | 17 | 2022 | 185 | 3.260 |
Why?
|
Urea | 6 | 2019 | 441 | 1.930 |
Why?
|
eIF-2 Kinase | 6 | 2018 | 144 | 1.880 |
Why?
|
Peptide Chain Initiation, Translational | 3 | 2013 | 100 | 0.900 |
Why?
|
Phosphorylation | 21 | 2022 | 8312 | 0.830 |
Why?
|
Antineoplastic Agents | 19 | 2019 | 13625 | 0.770 |
Why?
|
Protein Biosynthesis | 13 | 2023 | 2118 | 0.740 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 612 | 0.720 |
Why?
|
RNA, Transfer, Met | 3 | 2015 | 15 | 0.650 |
Why?
|
Heme | 2 | 2019 | 313 | 0.630 |
Why?
|
Clotrimazole | 2 | 2013 | 76 | 0.600 |
Why?
|
Biphenyl Compounds | 1 | 2022 | 987 | 0.600 |
Why?
|
Guanosine Triphosphate | 2 | 2015 | 316 | 0.570 |
Why?
|
Eukaryotic Initiation Factor-4G | 5 | 2014 | 69 | 0.520 |
Why?
|
Chromans | 3 | 2013 | 117 | 0.520 |
Why?
|
Structure-Activity Relationship | 13 | 2019 | 3087 | 0.490 |
Why?
|
Hydrazones | 6 | 2014 | 102 | 0.490 |
Why?
|
Thiazolidinediones | 5 | 2013 | 465 | 0.470 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1080 | 0.460 |
Why?
|
Enzyme Activators | 1 | 2013 | 57 | 0.450 |
Why?
|
Thiazoles | 8 | 2014 | 1501 | 0.440 |
Why?
|
Benzopyrans | 1 | 2013 | 63 | 0.430 |
Why?
|
Eukaryotic Initiation Factor-4E | 4 | 2014 | 112 | 0.400 |
Why?
|
Fish Oils | 1 | 2015 | 481 | 0.380 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2010 | 319 | 0.360 |
Why?
|
Cyclic AMP | 3 | 2003 | 1456 | 0.360 |
Why?
|
Oocytes | 3 | 2003 | 1169 | 0.340 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2019 | 717 | 0.320 |
Why?
|
Cell Line, Tumor | 19 | 2019 | 16878 | 0.310 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1146 | 0.310 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2010 | 417 | 0.280 |
Why?
|
Cell Proliferation | 13 | 2019 | 10427 | 0.280 |
Why?
|
Molecular Structure | 4 | 2019 | 1894 | 0.270 |
Why?
|
RNA, Messenger | 7 | 2023 | 12765 | 0.270 |
Why?
|
Prophase | 2 | 1995 | 16 | 0.270 |
Why?
|
Antigens, Surface | 1 | 2010 | 1607 | 0.260 |
Why?
|
Bacteriocins | 2 | 2019 | 89 | 0.260 |
Why?
|
NF-kappa B | 2 | 2013 | 2486 | 0.250 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11903 | 0.230 |
Why?
|
Interleukins | 2 | 2018 | 778 | 0.220 |
Why?
|
Granulosa Cells | 1 | 2003 | 117 | 0.210 |
Why?
|
Meiosis | 1 | 2003 | 327 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2019 | 10825 | 0.190 |
Why?
|
Indoles | 4 | 2013 | 1828 | 0.190 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1902 | 0.190 |
Why?
|
Activating Transcription Factor 4 | 2 | 2018 | 82 | 0.180 |
Why?
|
Nitro Compounds | 2 | 2012 | 74 | 0.170 |
Why?
|
Mice | 26 | 2021 | 80993 | 0.170 |
Why?
|
Mice, Nude | 4 | 2015 | 3602 | 0.170 |
Why?
|
Clodronic Acid | 1 | 2019 | 59 | 0.170 |
Why?
|
Animals | 34 | 2021 | 167531 | 0.170 |
Why?
|
Leishmania | 2 | 2017 | 68 | 0.160 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 482 | 0.160 |
Why?
|
Diphtheria Toxin | 1 | 2019 | 252 | 0.160 |
Why?
|
Trypanosoma brucei brucei | 1 | 2018 | 44 | 0.150 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5801 | 0.150 |
Why?
|
Cattle | 3 | 2003 | 3844 | 0.140 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1997 | 109 | 0.140 |
Why?
|
Complement System Proteins | 2 | 2011 | 781 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2013 | 3584 | 0.140 |
Why?
|
Listeriosis | 1 | 2018 | 148 | 0.140 |
Why?
|
Models, Molecular | 4 | 2019 | 5429 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-4F | 2 | 2017 | 42 | 0.140 |
Why?
|
Cyclin D1 | 3 | 2013 | 453 | 0.140 |
Why?
|
Cell Cycle | 3 | 2010 | 2936 | 0.130 |
Why?
|
Macrophages | 4 | 2020 | 5723 | 0.130 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2017 | 129 | 0.130 |
Why?
|
Cyclins | 2 | 2001 | 594 | 0.130 |
Why?
|
Listeria monocytogenes | 1 | 2018 | 249 | 0.130 |
Why?
|
Trypanosoma cruzi | 1 | 2018 | 205 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 2 | 2013 | 464 | 0.130 |
Why?
|
Simplexvirus | 1 | 2019 | 803 | 0.130 |
Why?
|
Intracellular Fluid | 1 | 1995 | 201 | 0.130 |
Why?
|
Mice, Inbred DBA | 3 | 2013 | 612 | 0.130 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2004 | 1387 | 0.120 |
Why?
|
Enzyme Activation | 3 | 2018 | 3604 | 0.120 |
Why?
|
Drug Design | 2 | 2017 | 1061 | 0.120 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 561 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2015 | 256 | 0.110 |
Why?
|
Breast Neoplasms | 3 | 2018 | 21019 | 0.110 |
Why?
|
Calcium | 7 | 2004 | 5718 | 0.110 |
Why?
|
Oncogene Proteins | 1 | 1997 | 721 | 0.110 |
Why?
|
Neoplasms | 3 | 2018 | 22023 | 0.110 |
Why?
|
RNA Interference | 3 | 2017 | 2848 | 0.100 |
Why?
|
Transfection | 4 | 2013 | 5781 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2419 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 302 | 0.100 |
Why?
|
Protozoan Proteins | 1 | 2018 | 837 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 1997 | 1078 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2015 | 813 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 775 | 0.100 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 273 | 0.100 |
Why?
|
Humans | 39 | 2023 | 759098 | 0.100 |
Why?
|
Sulfonamides | 2 | 2004 | 1972 | 0.090 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2011 | 51 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2013 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2522 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2011 | 277 | 0.090 |
Why?
|
3T3 Cells | 4 | 2001 | 1085 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1997 | 1708 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2393 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3449 | 0.080 |
Why?
|
Signal Transduction | 5 | 2017 | 23328 | 0.080 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 673 | 0.080 |
Why?
|
Erythrocytes | 1 | 2017 | 2416 | 0.080 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 691 | 0.070 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 522 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 943 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2011 | 1340 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 1997 | 2804 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2007 | 280 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2635 | 0.070 |
Why?
|
Hydrogen | 1 | 2007 | 171 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2017 | 3105 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2011 | 507 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2801 | 0.070 |
Why?
|
Bordetella pertussis | 2 | 1995 | 45 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3812 | 0.060 |
Why?
|
Apoptosis | 2 | 2018 | 9470 | 0.060 |
Why?
|
Thiones | 1 | 2004 | 46 | 0.060 |
Why?
|
Intestine, Small | 1 | 2011 | 1204 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7028 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2011 | 876 | 0.060 |
Why?
|
Cell Line | 3 | 2015 | 15638 | 0.060 |
Why?
|
Heme Oxygenase-1 | 2 | 2017 | 363 | 0.060 |
Why?
|
Culture Media | 2 | 1995 | 899 | 0.060 |
Why?
|
Carbon | 1 | 2007 | 670 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18094 | 0.050 |
Why?
|
Stereoisomerism | 2 | 2014 | 618 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4030 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2021 | 1756 | 0.050 |
Why?
|
Anemia, Hemolytic | 1 | 2003 | 163 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2014 | 3761 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9501 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2824 | 0.050 |
Why?
|
Adipocytes | 1 | 2007 | 1179 | 0.050 |
Why?
|
Protein Binding | 4 | 2015 | 9334 | 0.050 |
Why?
|
Transcription Factors | 2 | 2015 | 12106 | 0.040 |
Why?
|
G1 Phase | 2 | 2018 | 403 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1199 | 0.040 |
Why?
|
Chemokine CX3CL1 | 1 | 2020 | 64 | 0.040 |
Why?
|
Infertility, Male | 1 | 2003 | 396 | 0.040 |
Why?
|
MPTP Poisoning | 1 | 2019 | 37 | 0.040 |
Why?
|
Platelet Activation | 1 | 2003 | 661 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2004 | 1058 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2021 | 3534 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9587 | 0.040 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2018 | 87 | 0.040 |
Why?
|
Female | 12 | 2020 | 390174 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2017 | 4263 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1997 | 182 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1997 | 203 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 855 | 0.030 |
Why?
|
Myoblasts | 1 | 2018 | 235 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2017 | 8489 | 0.030 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1995 | 100 | 0.030 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 1995 | 73 | 0.030 |
Why?
|
Chagas Disease | 1 | 2018 | 167 | 0.030 |
Why?
|
Thapsigargin | 1 | 2015 | 102 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2018 | 14333 | 0.030 |
Why?
|
Thionucleotides | 1 | 1995 | 112 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1995 | 283 | 0.030 |
Why?
|
Oogenesis | 1 | 1995 | 124 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 21892 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 1995 | 322 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2017 | 381 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2011 | 6239 | 0.030 |
Why?
|
Cell Division | 2 | 2001 | 4445 | 0.030 |
Why?
|
RNA Caps | 1 | 2014 | 76 | 0.030 |
Why?
|
Tumor Cells, Cultured | 3 | 2011 | 6132 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2086 | 0.030 |
Why?
|
Isoquinolines | 1 | 1995 | 353 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1997 | 656 | 0.030 |
Why?
|
Interferon-beta | 1 | 2015 | 345 | 0.030 |
Why?
|
Melanoma | 1 | 2012 | 5690 | 0.030 |
Why?
|
Solutions | 1 | 2014 | 423 | 0.030 |
Why?
|
Host-Parasite Interactions | 1 | 2015 | 300 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1997 | 556 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 2014 | 200 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 428 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 426 | 0.030 |
Why?
|
Protein Transport | 1 | 2018 | 1967 | 0.030 |
Why?
|
Fetus | 1 | 2020 | 1862 | 0.030 |
Why?
|
Lung | 2 | 2021 | 9980 | 0.030 |
Why?
|
Ligands | 2 | 2014 | 3272 | 0.030 |
Why?
|
Binding Sites | 2 | 2014 | 6054 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 2011 | 68 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1244 | 0.020 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2011 | 7 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 454 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1230 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1695 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 5790 | 0.020 |
Why?
|
Specimen Handling | 1 | 1995 | 707 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2007 | 18937 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2568 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11461 | 0.020 |
Why?
|
Cytotoxins | 1 | 2011 | 153 | 0.020 |
Why?
|
Complement Membrane Attack Complex | 1 | 2010 | 105 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2018 | 2912 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 1978 | 0.020 |
Why?
|
Models, Chemical | 1 | 2011 | 615 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3664 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2017 | 2141 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4563 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3443 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 321 | 0.020 |
Why?
|
Male | 8 | 2020 | 358602 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2441 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2925 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1995 | 1665 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3201 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 462 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2134 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2011 | 1532 | 0.020 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2007 | 9 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2007 | 209 | 0.020 |
Why?
|
Time Factors | 4 | 2011 | 40083 | 0.020 |
Why?
|
Angiotensin II | 1 | 2010 | 850 | 0.020 |
Why?
|
Cell Extracts | 1 | 2007 | 135 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 633 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2897 | 0.020 |
Why?
|
Entropy | 1 | 2007 | 210 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2007 | 461 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2007 | 438 | 0.020 |
Why?
|
Neoplasms, Experimental | 2 | 2001 | 1230 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 871 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2007 | 736 | 0.020 |
Why?
|
Granulocytes | 1 | 2007 | 551 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1997 | 4492 | 0.020 |
Why?
|
PPAR gamma | 1 | 2007 | 484 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2011 | 1064 | 0.010 |
Why?
|
Feedback, Physiological | 1 | 2007 | 476 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7514 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2010 | 1436 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 935 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 511 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2113 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7583 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9460 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4325 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5637 | 0.010 |
Why?
|
Cyclin G | 1 | 2001 | 7 | 0.010 |
Why?
|
Cyclin G1 | 1 | 2001 | 15 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6143 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23577 | 0.010 |
Why?
|
Sperm Motility | 1 | 2003 | 266 | 0.010 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2004 | 420 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1343 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17611 | 0.010 |
Why?
|
Oncogenes | 1 | 2007 | 1221 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6538 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5841 | 0.010 |
Why?
|
Ploidies | 1 | 2000 | 275 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9410 | 0.010 |
Why?
|
Cyclin E | 1 | 2000 | 157 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1627 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3800 | 0.010 |
Why?
|
Spermatozoa | 1 | 2003 | 633 | 0.010 |
Why?
|
CHO Cells | 1 | 2001 | 1388 | 0.010 |
Why?
|
Introns | 1 | 2001 | 976 | 0.010 |
Why?
|
Ubiquitins | 1 | 2000 | 371 | 0.010 |
Why?
|
Protein Conformation | 1 | 2006 | 3969 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1135 | 0.010 |
Why?
|
Cricetinae | 1 | 2001 | 2424 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4283 | 0.010 |
Why?
|
Organ Specificity | 1 | 2001 | 1948 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2719 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2001 | 1744 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5214 | 0.010 |
Why?
|
Exons | 1 | 2001 | 2389 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2499 | 0.010 |
Why?
|
ras Proteins | 1 | 2000 | 1052 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13439 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5100 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2007 | 3959 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4625 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 4037 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2011 | 58864 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 9372 | 0.000 |
Why?
|
Phenotype | 1 | 2003 | 16524 | 0.000 |
Why?
|
Young Adult | 1 | 2011 | 58477 | 0.000 |
Why?
|
Adolescent | 1 | 2011 | 87551 | 0.000 |
Why?
|
Mutation | 1 | 2006 | 29878 | 0.000 |
Why?
|
Aged | 1 | 2011 | 168615 | 0.000 |
Why?
|
Middle Aged | 1 | 2011 | 219628 | 0.000 |
Why?
|
Adult | 1 | 2011 | 219353 | 0.000 |
Why?
|